| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-08-07 21:09 Tx date 2026-07-30 |
$TELO
Telo Genomics Corp. |
Price, John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,000,000 vol |
1,000,000 | |
| Filed 2026-08-07 21:07 Tx date 2026-01-30 |
$TELO
Telo Genomics Corp. |
Price, John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-08-07 21:07 Tx date 2026-03-06 |
$TELO
Telo Genomics Corp. |
Price, John
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+200,000 vol |
200,000 | |
| Filed 2026-08-07 21:05 Tx date 2026-01-30 |
$TELO
Telo Genomics Corp. |
Price, John
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-08-07 21:05 Tx date 2026-03-06 |
$TELO
Telo Genomics Corp. |
Price, John
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures
16 - Acquisition or disposition under a prospectus exemption
|
+$10,000 vol |
$10,000 | |
| Filed 2026-08-07 21:04 Tx date 2026-01-30 |
$TELO
Telo Genomics Corp. |
Price, John
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-08-05 18:29 Tx date 2025-04-04 |
$TELO
Telo Genomics Corp. |
Farlinger, John Allen
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
350,000 | ||
| Filed 2026-08-05 18:25 Tx date 2026-07-30 |
$TELO
Telo Genomics Corp. |
Farlinger, John Allen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
4,550,000 | |
| Filed 2026-06-25 19:20 Tx date 2025-04-04 |
$TELO
Telo Genomics Corp. |
Farlinger, John Allen
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-06-25 19:21 Tx date 2026-03-18 |
$TELO
Telo Genomics Corp. |
Farlinger, John Allen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+3,700,000 vol |
3,700,000 | |
| Filed 2026-06-25 19:20 Tx date 2025-04-04 |
$TELO
Telo Genomics Corp. |
Farlinger, John Allen
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-03-12 18:03 Tx date 2026-03-06 |
$TELO
Telo Genomics Corp. |
Farlinger, John Allen
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+700,000 vol |
700,000 | |
| Filed 2026-03-12 18:01 Tx date 2025-04-04 |
$TELO
Telo Genomics Corp. |
Farlinger, John Allen
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-03-12 18:01 Tx date 2026-03-06 |
$TELO
Telo Genomics Corp. |
Farlinger, John Allen
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures
16 - Acquisition or disposition under a prospectus exemption
|
+$35,000 vol |
$35,000 | |
| Filed 2026-03-12 18:00 Tx date 2025-04-04 |
$TELO
Telo Genomics Corp. |
Farlinger, John Allen
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-03-06 16:59 Tx date 2025-04-04 |
$TELO
Telo Genomics Corp. |
Farlinger, John Allen
4 - Director of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
30,530 | ||
| Filed 2025-03-11 18:06 Tx date 2025-03-06 |
$TELO
Telo Genomics Corp. |
Ross, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$22,500
+150,000 vol $0.15 each |
250,000 | |
| Filed 2025-03-11 18:04 Tx date 2025-03-06 |
$TELO
Telo Genomics Corp. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$52,500
+350,000 vol $0.15 each |
650,000 | |
| Filed 2025-03-11 18:03 Tx date 2025-03-06 |
$TELO
Telo Genomics Corp. |
Mai, Sabine
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$75,000
+500,000 vol $0.15 each |
1,280,752 | |
| Filed 2025-03-11 18:01 Tx date 2025-03-06 |
$TELO
Telo Genomics Corp. |
Baechler, Guido
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$150,000
+1,000,000 vol $0.15 each |
1,700,000 |